Jaguar Health (JAGX) Accumulated Expenses (2014 - 2026)
Jaguar Health's (JAGX) quarterly Accumulated Expenses came in at $4000.0 in Q1 2026, down 99.81% year-on-year from $2.1 million in Q1 2025, and down 98.88% on a QoQ basis from $357000.0 in Q4 2025.
Jaguar Health (JAGX) Accumulated Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Accumulated Expenses data on file, last reported at $4000.0 in Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 99.81% year-over-year to $4000.0 in Q1 2026; TTM through Mar 2026 was $4000.0, a 99.81% decrease from a year earlier, with the FY2025 full-year figure at $357000.0, down 81.32% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $4000.0, down from $357000.0 in the prior quarter.
- Over the last five years, Accumulated Expenses for JAGX reached as high as $10.0 million in Q2 2023 and fell as low as $4000.0 in Q1 2026.
- Historically, Accumulated Expenses has averaged $4.5 million across 5 years, with a median of $3.5 million in 2024.
- Across the five-year window, Accumulated Expenses soared 1853.38% in 2022 and slumped 99.81% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $5.5 million in 2022, then tumbled by 96.21% to $208000.0 in 2023, then surged by 818.75% to $1.9 million in 2024, then tumbled by 81.32% to $357000.0 in 2025, then slumped by 98.88% to $4000.0 in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $4000.0 in Q1 2026, $357000.0 in Q4 2025, and $4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 357,000.00 |
| Sep 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | 3.46 Mn |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 3.29 Mn |
| Jun 30, 2023 | 10.02 Mn |
| Mar 31, 2023 | 9.28 Mn |
| Dec 31, 2022 | 5.49 Mn |
| Sep 30, 2022 | 8.50 Mn |
| Jun 30, 2022 | 8.91 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Dec 31, 2021 | 281,000.00 |
| Sep 30, 2021 | 6.08 Mn |
| Jun 30, 2021 | 6.38 Mn |